Literature DB >> 21990094

A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis.

Mary Frances McMullin1, Chao Wu, Melanie J Percy, Wei Tong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21990094      PMCID： PMC3674579          DOI： 10.1002/ajh.22154

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  19 in total

1.  LNK mutations in JAK2 mutation-negative erythrocytosis.

Authors:  Terra L Lasho; Animesh Pardanani; Ayalew Tefferi
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

2.  LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.

Authors:  A Pardanani; T Lasho; C Finke; S T Oh; J Gotlib; A Tefferi
Journal:  Leukemia       Date:  2010-08-19       Impact factor: 11.528

Review 3.  HIF pathway mutations and erythrocytosis.

Authors:  Mary Frances McMullin
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

4.  Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.

Authors:  Fanny Baran-Marszak; Hajer Magdoud; Christophe Desterke; Anabell Alvarado; Claudine Roger; Stéphanie Harel; Elizabeth Mazoyer; Bruno Cassinat; Sylvie Chevret; Carole Tonetti; Stéphane Giraudier; Pierre Fenaux; Florence Cymbalista; Nadine Varin-Blank; Marie-Caroline Le Bousse-Kerdilès; Jean-Jacques Kiladjian; Laura Velazquez
Journal:  Blood       Date:  2010-09-24       Impact factor: 22.113

5.  The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients.

Authors:  Elena Y Lavrikova; Alexey G Nikitin; Tamara L Kuraeva; Valentina A Peterkova; Nina M Tsitlidze; Dimitry A Chistiakov; Valery V Nosikov
Journal:  Pediatr Diabetes       Date:  2011-03       Impact factor: 4.866

6.  An efficient procedure for genotyping single nucleotide polymorphisms.

Authors:  S Ye; S Dhillon; X Ke; A R Collins; I N Day
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

7.  Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Authors:  Wei Tong; Jing Zhang; Harvey F Lodish
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

8.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

9.  Genome-wide association study of blood pressure and hypertension.

Authors:  Daniel Levy; Georg B Ehret; Kenneth Rice; Germaine C Verwoert; Lenore J Launer; Abbas Dehghan; Nicole L Glazer; Alanna C Morrison; Andrew D Johnson; Thor Aspelund; Yurii Aulchenko; Thomas Lumley; Anna Köttgen; Ramachandran S Vasan; Fernando Rivadeneira; Gudny Eiriksdottir; Xiuqing Guo; Dan E Arking; Gary F Mitchell; Francesco U S Mattace-Raso; Albert V Smith; Kent Taylor; Robert B Scharpf; Shih-Jen Hwang; Eric J G Sijbrands; Joshua Bis; Tamara B Harris; Santhi K Ganesh; Christopher J O'Donnell; Albert Hofman; Jerome I Rotter; Josef Coresh; Emelia J Benjamin; André G Uitterlinden; Gerardo Heiss; Caroline S Fox; Jacqueline C M Witteman; Eric Boerwinkle; Thomas J Wang; Vilmundur Gudnason; Martin G Larson; Aravinda Chakravarti; Bruce M Psaty; Cornelia M van Duijn
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

10.  Genome-wide association study identifies eight loci associated with blood pressure.

Authors:  Christopher Newton-Cheh; Toby Johnson; Vesela Gateva; Martin D Tobin; Murielle Bochud; Lachlan Coin; Samer S Najjar; Jing Hua Zhao; Simon C Heath; Susana Eyheramendy; Konstantinos Papadakis; Benjamin F Voight; Laura J Scott; Feng Zhang; Martin Farrall; Toshiko Tanaka; Chris Wallace; John C Chambers; Kay-Tee Khaw; Peter Nilsson; Pim van der Harst; Silvia Polidoro; Diederick E Grobbee; N Charlotte Onland-Moret; Michiel L Bots; Louise V Wain; Katherine S Elliott; Alexander Teumer; Jian'an Luan; Gavin Lucas; Johanna Kuusisto; Paul R Burton; David Hadley; Wendy L McArdle; Morris Brown; Anna Dominiczak; Stephen J Newhouse; Nilesh J Samani; John Webster; Eleftheria Zeggini; Jacques S Beckmann; Sven Bergmann; Noha Lim; Kijoung Song; Peter Vollenweider; Gerard Waeber; Dawn M Waterworth; Xin Yuan; Leif Groop; Marju Orho-Melander; Alessandra Allione; Alessandra Di Gregorio; Simonetta Guarrera; Salvatore Panico; Fulvio Ricceri; Valeria Romanazzi; Carlotta Sacerdote; Paolo Vineis; Inês Barroso; Manjinder S Sandhu; Robert N Luben; Gabriel J Crawford; Pekka Jousilahti; Markus Perola; Michael Boehnke; Lori L Bonnycastle; Francis S Collins; Anne U Jackson; Karen L Mohlke; Heather M Stringham; Timo T Valle; Cristen J Willer; Richard N Bergman; Mario A Morken; Angela Döring; Christian Gieger; Thomas Illig; Thomas Meitinger; Elin Org; Arne Pfeufer; H Erich Wichmann; Sekar Kathiresan; Jaume Marrugat; Christopher J O'Donnell; Stephen M Schwartz; David S Siscovick; Isaac Subirana; Nelson B Freimer; Anna-Liisa Hartikainen; Mark I McCarthy; Paul F O'Reilly; Leena Peltonen; Anneli Pouta; Paul E de Jong; Harold Snieder; Wiek H van Gilst; Robert Clarke; Anuj Goel; Anders Hamsten; John F Peden; Udo Seedorf; Ann-Christine Syvänen; Giovanni Tognoni; Edward G Lakatta; Serena Sanna; Paul Scheet; David Schlessinger; Angelo Scuteri; Marcus Dörr; Florian Ernst; Stephan B Felix; Georg Homuth; Roberto Lorbeer; Thorsten Reffelmann; Rainer Rettig; Uwe Völker; Pilar Galan; Ivo G Gut; Serge Hercberg; G Mark Lathrop; Diana Zelenika; Panos Deloukas; Nicole Soranzo; Frances M Williams; Guangju Zhai; Veikko Salomaa; Markku Laakso; Roberto Elosua; Nita G Forouhi; Henry Völzke; Cuno S Uiterwaal; Yvonne T van der Schouw; Mattijs E Numans; Giuseppe Matullo; Gerjan Navis; Göran Berglund; Sheila A Bingham; Jaspal S Kooner; John M Connell; Stefania Bandinelli; Luigi Ferrucci; Hugh Watkins; Tim D Spector; Jaakko Tuomilehto; David Altshuler; David P Strachan; Maris Laan; Pierre Meneton; Nicholas J Wareham; Manuela Uda; Marjo-Riitta Jarvelin; Vincent Mooser; Olle Melander; Ruth J F Loos; Paul Elliott; Gonçalo R Abecasis; Mark Caulfield; Patricia B Munroe
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330
View more
  18 in total

1.  LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.

Authors:  Wei Wang; Yang Tang; Ying Wang; Liana Tascau; Joanna Balcerek; Wei Tong; Ross L Levine; Carrie Welch; Alan R Tall; Nan Wang
Journal:  Circ Res       Date:  2016-07-18       Impact factor: 17.367

2.  Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.

Authors:  Ambra Spolverini; Lisa Pieri; Paola Guglielmelli; Alessandro Pancrazzi; Tiziana Fanelli; Chiara Paoli; Alberto Bosi; Ilaria Nichele; Marco Ruggeri; Alessandro M Vannucchi
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 3.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Authors:  N Maslah; B Cassinat; E Verger; J-J Kiladjian; L Velazquez
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

Review 4.  Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis.

Authors:  Pradeep Natarajan; Siddhartha Jaiswal; Sekar Kathiresan
Journal:  Circ Genom Precis Med       Date:  2018-07

Review 5.  Monocyte-Macrophages and T Cells in Atherosclerosis.

Authors:  Ira Tabas; Andrew H Lichtman
Journal:  Immunity       Date:  2017-10-17       Impact factor: 31.745

6.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 7.  12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?

Authors:  Georg Auburger; Suzana Gispert; Suna Lahut; Ozgür Omür; Ewa Damrath; Melanie Heck; Nazlı Başak
Journal:  World J Diabetes       Date:  2014-06-15

8.  SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Authors:  Maya Koren-Michowitz; Sigal Gery; Takayuki Tabayashi; Dechen Lin; Rocio Alvarez; Arnon Nagler; H Phillip Koeffler
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

9.  Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.

Authors:  Carme Camps; Nayia Petousi; Celeste Bento; Holger Cario; Richard R Copley; Mary Frances McMullin; Richard van Wijk; Peter J Ratcliffe; Peter A Robbins; Jenny C Taylor
Journal:  Haematologica       Date:  2016-09-20       Impact factor: 9.941

10.  Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.

Authors:  Felix C Giani; Claudia Fiorini; Aoi Wakabayashi; Leif S Ludwig; Rany M Salem; Chintan D Jobaliya; Stephanie N Regan; Jacob C Ulirsch; Ge Liang; Orna Steinberg-Shemer; Michael H Guo; Tõnu Esko; Wei Tong; Carlo Brugnara; Joel N Hirschhorn; Mitchell J Weiss; Leonard I Zon; Stella T Chou; Deborah L French; Kiran Musunuru; Vijay G Sankaran
Journal:  Cell Stem Cell       Date:  2015-10-22       Impact factor: 24.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.